Ningxia Tairui Pharmaceutical Co., Ltd is a technologically advanced company focusing on the R&D, production and marketing of veterinary APIs and formulations. Our leading products include Tylosin (Base/ Tartrate/ Phosphate), Tilmicosin (base/ phosphate), Acetylisovaleryltylosin Tartrate, Tiamulin Fumarate, CTC feed grade(15%,20%) and Erythromycin Thiocyanate. We are the largest producer of Tylosin in the world.

We place strong emphasis on product quality. All of our products have China GMP certification, ISO9001 and ISO14001 certification. We are in the process of applying for USA FDA certification for six of our products and COS of European Pharmacopoeia Commission certification for two of our products. Our product quality has been affirmed by customers from 80 countries, including the Netherlands, Germany, Switzerland, Australia, USA and India. We highly value our brand equity and image, and have registered “TAIRUI” for the Madrid Agreement Concerning the International Registration of Marks in Germany and USA.

As China’s Top 50 Veterinary Pharmaceutical Enterprise, China’s Top 10 Veterinary API Enterprise, and an AAA credit rating company, Tairui Pharma, owns a State-level Enterprise Technical Center and an Engineering Laboratory.

With a track record of positive achievements, Tairui Pharma has always emphasized the development and introduction of new technologies and products in its Nationally ranked R&D Center, state-of-the-art facilities and well-equipped laboratory, allowing it to meet the growing and evolving demands of customers both at home and abroad.

Following our motto of "Promoting social welfare , Serving the healthcare industry" and undertaking the responsibility of advancing the development of the pharmaceutical industry, Tairui Pharma will always strive to be a world-class API production base and distribute its products and services to customers worldwide.